CoreCap Advisors »

Rapt Therapeutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3k 629 2.01

More positions owned by CoreCap Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Select Sector Spdr Tr Technology (XLK)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Amazon (AMZN)

View all positions for CoreCap Advisors

Top funds holding Rapt Therapeutics

Vanguard Group
Column Group
BlackRock
BlackRock
Kingdon Capital Management
Morgan Stanley
D. E. Shaw & Co
Acadian Asset Management
Federated Investors
Two Sigma Advisers
Geode Capital Management
State Street Corporation
Euclidean Capital
Two Sigma Investments
Alphabet

View all funds holding Rapt Therapeutics